Skip to main content

Table 8 Indications for 25(OH)D evaluation (besides rickets) in children and adolescents as proposed by various Organizations and Societies

From: Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians

Organization/Society, year of publication

PES, 2008 [9]

ES, 2011 [11]

FCN, 2012 [15]

French Soc. of Pediatrics, 2012a [13]

Australia - New Zealand, 2013 [22]

Central Europe, 2013 [20]

SAHM, 2013 [21]

AAP, 2014 [23]

Arab Emirates, 2016 [27]

EAP, 2017 [30]

Frequent/low trauma fractures and/or low BMD

X

X

X

  

X

X

Xb

X

 

Calcium/phosphate metabolism abnormalities

     

X

  

X

 

Immobilization/disabilities

    

X

 

X

X

X

 

Dark skin pigmentation

Xc

Xd

X

X

X

 

X

  

X

Reduced sun exposure

X

  

X

X

 

X

  

X

 Athletes (indoor sports)

  

X

       

 Children institutionalized

        

X

X

 Constant use of sunscreens

      

X

   

Obesity

 

X

Xe

X

X

 

X

 

X

 

Inadequate diets (e.g. vegan)

   

X

  

X

  

X

Elimination diets (e.g. cow/s milk allergy), eating disorders

     

X

 

X

X

 

On anticonvulsants

X

X

X

X

X

X

X

X

X

X

On chronic glucocorticoids

X

X

X

  

X

X

X

X

 

On HIV medications

 

X

X

  

X

X

 

X

 

On antifungals (e.g. ketoconazole)

 

X

X

  

X

  

X

 

On rifampicin

   

X

X

     

Malabsorption syndromes

X

X

X

X

X

X

X

X

X

X

Chronic kidney disease

 

X

X

X

X

X

X

X

X

X

Nephrotic syndrome

   

X

      

Hepatic failure and/or cholestasis

 

X

X

X

X

X

X

 

X

X

Granulomatous disorders (e.g. tuberculosis)

 

X

X

  

X

  

X

 

Amenorrhea

      

X

   

Cancer (different types)

 

Xf

   

X

 

X

X

 

Hepatitis Cg

     

X

  

X

 

Recurrent acute lower respiratory tract infectionsg

     

X

  

X

 

Atopic dermatitisg

     

X

  

X

 

Atopic Asthmag

     

X

  

X

 

Autoimmune diseasesh

     

X

 

Xi

X

 

Cardiovascular diseases (especially hypertension)

     

X

  

X

 

Metabolic syndrome, type 2 diabetes

        

X

 
  1. PES Pediatric Endocrine Society, ES Endocrine Society, FCN Federal Commission for Nutrition (Switzerland), SAHM Society for adolescent health and medicine, AAP American Academy of Pediatrics, EAP European Academy of Pediatrics
  2. asuggested to guide vitamin D prescription in individuals with underlying risks requiring continuing supplementation all year long, if necessary
  3. bgenetic conditions (osteogenesis imperfecta, idiopathic juvenile osteoporosis, Turner syndrome), endocrine conditions (Cushing syndrome, hypogonadism, hyperthyroidism, hyperparathyroidism, growth hormone deficiency, diabetes mellitus) associated with reduced bone mass
  4. cliving at higher latitudes in the winter and spring months
  5. dAfrican-American and Hispanic children
  6. eobese children with additional risk factors/symptoms for vitamin D deficiency
  7. f some lymphomas
  8. gpatients admitted to hospital
  9. hmultiple sclerosis, psoriasis, rheumatoid arthritis, dermatomyositis, systemic lupus erythematosus
  10. i systemic lupus erythematosus, juvenile idiopathic arthritis, juvenile dermatomyositis as associated with reduced bone mass